Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 Deficiency. Zhen X, Betti MJ, Kars ME, Patterson AR, Medina-Torres EA, Scheffler Mendoza SC, Herrera Sánchez DA, Lopez-Herrera G, Svyryd Y, Mutchinick OM, Gamazon ER, Rathmell JC, Itan Y, Markle J, O'Farrill Romanillos P, Lugo-Reyes SO, Martinez-Barricarte R.J Clin Immunol. 2024 Dec 4;45(1):53. doi: 10.1007/s10875-024-01836-0.PMID: 39630167
Aplastic anemia related to a novel CTLA4 variant. Hall G, Markle JG, Maiarana J, Martin PL, Rothman JA, Sleasman JW, Lederman H, Azar AE, Brodsky RA, Mousallem T.Front Pediatr. 2024 Aug 16;12:1434076. doi: 10.3389/fped.2024.1434076. eCollection 2024.PMID: 39220156
Functional overlap of inborn errors of immunity and metabolism genes defines T cell metabolic vulnerabilities. Patterson AR, Needle GA, Sugiura A, Jennings EQ, Chi C, Steiner KK, Fisher EL, Robertson GL, Bodnya C, Markle JG, Sheldon RD, Jones RG, Gama V, Rathmell JC.Sci Immunol. 2024 Aug 16;9(98):eadh0368. doi: 10.1126/sciimmunol.adh0368. Epub 2024 Aug 16.PMID: 39151020
Immune dysregulation due to bi-allelic mutation of the actin remodeling protein DIAPH1. Bhattad S, Ramakrishna SH, Kumar R, Choi JM, Markle JG.Front Immunol. 2024 Jul 15;15:1406781. doi: 10.3389/fimmu.2024.1406781. eCollection 2024.PMID: 39076976
Expanding the molecular and phenotypic spectrum of CTLA-4 insufficiency. Duke S, Maiarana J, Yousefi P, Burks E, Gerrie S, Setiadi A; BC Children's and St Paul's Hospital Members; Hildebrand KJ, James E, Turvey SE, Markle JG, Biggs CM. Pediatr Allergy Immunol. 2024 Feb;35(2):e14077. doi: 10.1111/pai.14077.PMID: 38351878
Clinical and cellular phenotypes resulting from a founder mutation in IL10RB. Mao Z, Betti MJ, Cedeno MA, Pedroza LA, Basaria S, Liu Q, Choi JM, Markle JG.Clin Exp Immunol. 2024 Apr 23;216(2):113-119. doi: 10.1093/cei/uxad085.PMID: 37503744
Deep immunophenotyping shows altered immune cell subsets in CTLA-4 haploinsufficiency. Maiarana J, Moncada-Velez M, Malbran E, Torre MG, Elonen C, Malbran A, Markle JG. Pediatr Allergy Immunol. 2023 Jul;34(7):e13994. doi: 10.1111/pai.13994.PMID: 37492916
14. Boisson-Dupuis, S., Ramirez-Alejo, N., Li, Z., Patin, E., Rao, G., Kerner, G., Lim, C. K., Krementsov, D. N., Hernandez, N., Ma, C. S., Zhang, Q., Markle, J., Martinez-Barricarte, R., Payne, K., Fisch, R., Deswarte, C., Halpern, J., Bouaziz, M., Mulwa, J., … Casanova, J.L. (2018). Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Science Immunology, 3(30). https://doi.org/10.1126/sciimmunol.aau8714
15. Metz, K. A., Teng, X., Coppens, I., Lamb, H. M., Wagner, B. E., Rosenfeld, J. A., Chen, X., Zhang, Y., Kim, H. J., Meadow, M. E., Wang, T. S., Haberlandt, E. D., Anderson, G. W., Leshinsky-Silver, E., Bi, W., Markello, T. C., Pratt, M., Makhseed, N., Garnica, A., Danylchuk, N. R., Burrow, T. A., Jayakar, P., McKnight, D., Agadi, S., Gbedawo, H., Stanley, C., Alber, M., Prehl, I., Peariso, K., Ong, M. T., Mordekar, S. R., Parker, M. J., Crooks, D., Agrawal, P. B., Berry, G. T., Loddenkemper, T., Yang, Y., Maegawa, G. H. B., Aouacheria, A., Markle, J. G., Wohlschlegel, J. A., Hartman, A. L., & Hardwick, J. M.(2018). KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy‐lysosome defect. Annals of Neurology, 84(5), 766–780. https://doi.org/10.1002/ana.25351
19. Parvaneh, N., Barlogis, V., Alborzi, A., Deswarte, C., Boisson-Dupuis, S., Migaud, M., Farnaria, C., Markle, J., Parvaneh, L., Casanova, J.-L., & Bustamante, J. (2016). Visceral leishmaniasis in two patients with IL-12p40 and IL-12Rβ1 deficiencies. Pediatric Blood & Cancer, 64(6). https://doi.org/10.1002/pbc.26362
24. Motta, V. N., Markle, J. G., Gulban, O., Mortin-Toth, S., Liao, K.-C., Mogridge, J., Steward, C. A., & Danska, J. S. (2015). Identification of the inflammasome Nlrp1b as the candidate gene conferring diabetes risk at the Idd4.1 locus in the nonobese diabetic mouse. The Journal of Immunology, 194(12), 5663–5673. https://doi.org/10.4049/jimmunol.1400913